PF-07328948 is a small molecule drug developed by Pfizer Inc. The drug targets BCKDK and falls within the therapeutic area of cardiovascular diseases.

Fentanyl Citrate is a small molecule drug that targets the μ opioid receptor and is used to treat a range of therapeutic areas including nervous system diseases.

Osimertinib mesylate is a small molecule drug that targets EGFR L858R, EGFR T790M, and EGFR-Ex19del.

NDI-101150 is a small molecule drug developed by Nimbus Therapeutics LLC, aimed at targeting the HPK1 protein.

Elacestrant hydrochloride is a small molecule drug that targets ERα and is used in the treatment of various therapeutic areas.

Orforglipron is a small molecule drug that targets the GLP-1R, with therapeutic applications in Nervous System Diseases.

IWY-357 is a small molecule drug developed by Novartis AG, with a focus on the therapeutic area of infectious diseases.

Deutetrabenazine is a small molecule drug that targets VMAT2 and is used in the treatment of nervous system diseases, congenital disorders, and other diseases.

Iptacopan is a small molecule drug that targets the complement factor B (CFB) and has been approved for various therapeutic areas.

CC-91633 is a novel molecular glue drug that targets CK1α and falls within the therapeutic areas of neoplasms, hemic and lymphatic diseases.

Daprodustat is a small molecule drug developed by GSK Plc which primarily targets Hypoxia-Inducible Factor-Prolyl Hydroxylase (HIF-PH) enzymes.

Ibrutinib is a medication used primarily in the treatment of certain types of cancer, particularly B-cell malignancies.